<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;ff=20240402041101&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;v=2.18.0.post9+e462414&amp;ff=20240402041101&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 02 Apr 2024 08:11:03 +0000</lastbuilddate>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38561163/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Mar 30:S0735-1097(24)06820-7. doi: 10.1016/j.jacc.2024.03.414. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38561163/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38561163</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.03.414>10.1016/j.jacc.2024.03.414</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38561163</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Pedro R Moreno</dc:creator>
<dc:creator>Valentin Fuster</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction</dc:title>
<dc:identifier>pmid:38561163</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.03.414</dc:identifier>
</item>
<item>
<title>Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1;45(13):1089-1093. doi: 10.1093/eurheartj/ehae180.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38558243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae180>10.1093/eurheartj/ehae180</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558243</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention</dc:title>
<dc:identifier>pmid:38558243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae180</dc:identifier>
</item>
<item>
<title>Fifty years of percutaneous transluminal angioplasty</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558170/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1:ehae145. doi: 10.1093/eurheartj/ehae145. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558170/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38558170</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae145>10.1093/eurheartj/ehae145</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558170</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Marco Roffi</dc:creator>
<dc:creator>Bernhard Meier</dc:creator>
<dc:creator>Augusto Gallino</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Fifty years of percutaneous transluminal angioplasty</dc:title>
<dc:identifier>pmid:38558170</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae145</dc:identifier>
</item>
<item>
<title>Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38558097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093/eurheartj/ehae138. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38558097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38558097</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae138>10.1093/eurheartj/ehae138</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38558097</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Giovanna Liuzzo</dc:creator>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation</dc:title>
<dc:identifier>pmid:38558097</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae138</dc:identifier>
</item>
<item>
<title>Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557127/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1087-1089. doi: 10.1161/CIRCULATIONAHA.123.067916. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557127/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557127</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067916>10.1161/CIRCULATIONAHA.123.067916</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557127</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Akiko Maehara</dc:creator>
<dc:creator>Yoichiro Sugizaki</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Intravascular Imaging for Guiding Percutaneous Coronary Intervention: What Does the Totality of Data Suggest, and Where Should We Go?</dc:title>
<dc:identifier>pmid:38557127</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067916</dc:identifier>
</item>
<item>
<title>Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557126/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):e1066. doi: 10.1161/CIR.0000000000001235. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557126/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557126</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001235>10.1161/CIR.0000000000001235</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557126</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: INO80-Dependent Remodeling of Transcriptional Regulatory Network Underlies the Progression of Heart Failure</dc:title>
<dc:identifier>pmid:38557126</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001235</dc:identifier>
</item>
<item>
<title>Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557125/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1147-1149. doi: 10.1161/CIRCULATIONAHA.123.065513. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557125/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557125</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065513>10.1161/CIRCULATIONAHA.123.065513</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557125</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Priyanka Gokulnath</dc:creator>
<dc:creator>Michail Spanos</dc:creator>
<dc:creator>H Immo Lehmann</dc:creator>
<dc:creator>Quanhu Sheng</dc:creator>
<dc:creator>Rodosthenis Rodosthenous</dc:creator>
<dc:creator>Mark Chaffin</dc:creator>
<dc:creator>Dimitrios Varrias</dc:creator>
<dc:creator>Emeli Chatterjee</dc:creator>
<dc:creator>Elizabeth Hutchins</dc:creator>
<dc:creator>Guoping Li</dc:creator>
<dc:creator>George Daaboul</dc:creator>
<dc:creator>Farhan Rana</dc:creator>
<dc:creator>Ashley Mingyi Wang</dc:creator>
<dc:creator>Kendall Van Keuren-Jensen</dc:creator>
<dc:creator>Patrick T Ellinor</dc:creator>
<dc:creator>Ravi Shah</dc:creator>
<dc:creator>Saumya Das</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Distinct Plasma Extracellular Vesicle Transcriptomes in Acute Decompensated Heart Failure Subtypes: A Liquid Biopsy Approach</dc:title>
<dc:identifier>pmid:38557125</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065513</dc:identifier>
</item>
<item>
<title>Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557124/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1059-1061. doi: 10.1161/CIRCULATIONAHA.123.066984. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557124/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557124</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066984>10.1161/CIRCULATIONAHA.123.066984</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557124</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Sumeet S Chugh</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators</dc:title>
<dc:identifier>pmid:38557124</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066984</dc:identifier>
</item>
<item>
<title>Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557123/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1062-1064. doi: 10.1161/CIRCULATIONAHA.123.068066. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557123/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557123</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068066>10.1161/CIRCULATIONAHA.123.068066</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557123</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Chris J Kapelios</dc:creator>
<dc:creator>Lars H Lund</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart Failure</dc:title>
<dc:identifier>pmid:38557123</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068066</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557122/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 2;149(14):1139-1144. doi: 10.1161/CIRCULATIONAHA.124.069400. Epub 2024 Apr 1.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557122/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557122</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069400>10.1161/CIRCULATIONAHA.124.069400</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557122</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:38557122</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069400</dc:identifier>
</item>
<item>
<title>CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557119/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Distinct from its canonical function in strengthening cell adhesion at cell surface, CD151 maintains endolysosome function by sustaining VCP/p97-mediated protein unfolding and turnover. By supporting protein quality control and protein degradation, CD151 prevents proteins from (1) buildup in endolysosomes and (2) discharge through exosomes, to limit vascular inflammation. Also, our study conceptualizes that balance between degradation and discharge of proteins in endothelial cells...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Apr 1. doi: 10.1161/CIRCRESAHA.123.323190. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Tetraspanin CD151 is highly expressed in endothelia and reinforces cell adhesion, but its role in vascular inflammation remains largely unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In vitro molecular and cellular biological analyses on genetically modified endothelial cells, in vivo vascular biological analyses on genetically engineered mouse models, and in silico systems biology and bioinformatics analyses on CD151-related events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Endothelial ablation of <i>Cd151</i> leads to pulmonary and cardiac inflammation, severe sepsis, and perilous COVID-19, and endothelial CD151 becomes downregulated in inflammation. Mechanistically, CD151 restrains endothelial release of proinflammatory molecules for less leukocyte infiltration. At the subcellular level, CD151 determines the integrity of multivesicular bodies/lysosomes and confines the production of exosomes that carry cytokines such as ANGPT2 (angiopoietin-2) and proteases such as cathepsin-D. At the molecular level, CD151 docks VCP (valosin-containing protein)/p97, which controls protein quality via mediating deubiquitination for proteolytic degradation, onto endolysosomes to facilitate VCP/p97 function. At the endolysosome membrane, CD151 links VCP/p97 to (1) IFITM3, which regulates multivesicular body functions, to restrain IFITM3-mediated exosomal sorting, and (2) V-ATPase, which dictates endolysosome pH, to support functional assembly of V-ATPase.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Distinct from its canonical function in strengthening cell adhesion at cell surface, CD151 maintains endolysosome function by sustaining VCP/p97-mediated protein unfolding and turnover. By supporting protein quality control and protein degradation, CD151 prevents proteins from (1) buildup in endolysosomes and (2) discharge through exosomes, to limit vascular inflammation. Also, our study conceptualizes that balance between degradation and discharge of proteins in endothelial cells determines vascular information. Thus, the IFITM3/V-ATPase-tetraspanin-VCP/p97 complexes on endolysosome, as a protein quality control and inflammation-inhibitory machinery, could be beneficial for therapeutic intervention against vascular inflammation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557119/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557119</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323190>10.1161/CIRCRESAHA.123.323190</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557119</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Junxiong Chen</dc:creator>
<dc:creator>Yingjun Ding</dc:creator>
<dc:creator>Chao Jiang</dc:creator>
<dc:creator>Rongmei Qu</dc:creator>
<dc:creator>Jonathan D Wren</dc:creator>
<dc:creator>Constantin Georgescu</dc:creator>
<dc:creator>Xuejun Wang</dc:creator>
<dc:creator>Darlene N Reuter</dc:creator>
<dc:creator>Beibei Liu</dc:creator>
<dc:creator>Cory B Giles</dc:creator>
<dc:creator>Christoph H Mayr</dc:creator>
<dc:creator>Herbert B Schiller</dc:creator>
<dc:creator>Jingxing Dai</dc:creator>
<dc:creator>Christopher S Stipp</dc:creator>
<dc:creator>Bharathiraja Subramaniyan</dc:creator>
<dc:creator>Jie Wang</dc:creator>
<dc:creator>Houjuan Zuo</dc:creator>
<dc:creator>Chao Huang</dc:creator>
<dc:creator>Kar-Ming Fung</dc:creator>
<dc:creator>Heather C Rice</dc:creator>
<dc:creator>Arnoud Sonnenberg</dc:creator>
<dc:creator>David Wu</dc:creator>
<dc:creator>Matthew S Walters</dc:creator>
<dc:creator>You-Yang Zhao</dc:creator>
<dc:creator>Tomoharu Kanie</dc:creator>
<dc:creator>Franklin A Hays</dc:creator>
<dc:creator>James F Papin</dc:creator>
<dc:creator>Dao Wen Wang</dc:creator>
<dc:creator>Xin A Zhang</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation</dc:title>
<dc:identifier>pmid:38557119</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323190</dc:identifier>
</item>
<item>
<title>Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557064/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.124.069553. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557064/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557064</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069553>10.1161/CIRCULATIONAHA.124.069553</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557064</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Joseph C Wu</dc:creator>
<dc:creator>B Hadley Wilson</dc:creator>
<dc:creator>James C Fang</dc:creator>
<dc:creator>Jodie L Hurwitz</dc:creator>
<dc:creator>George D Dangas</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth</dc:title>
<dc:identifier>pmid:38557064</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069553</dc:identifier>
</item>
<item>
<title>LXRα Promotes Abdominal Aortic Aneurysm Formation Through UHRF1 Epigenetic Modification of miR-26b-3p</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557060/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our study reveals a pivotal role of the LXRα/UHRF1/miR-26b-3p axis in AAA and provides potential biomarkers and therapeutic targets for AAA.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.065202. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Abdominal aortic aneurysm (AAA) is a severe aortic disease without effective pharmacological approaches. The nuclear hormone receptor LXRα (liver X receptor α), encoded by the <i>NR1H3</i> gene, serves as a critical transcriptional mediator linked to several vascular pathologies, but its role in AAA remains elusive.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Through integrated analyses of human and murine AAA gene expression microarray data sets, we identified <i>NR1H3</i> as a candidate gene regulating AAA formation. To investigate the role of LXRα in AAA formation, we used global <i>Nr1h3</i>-knockout and vascular smooth muscle cell-specific <i>Nr1h3</i>-knockout mice in 2 AAA mouse models induced with angiotensin II (1000 ng·kg·min; 28 days) or calcium chloride (CaCl<sub>2</sub>; 0.5 mol/L; 42 days).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Upregulated LXRα was observed in the aortas of patients with AAA and in angiotensin II- or CaCl<sub>2</sub>-treated mice. Global or vascular smooth muscle cell-specific <i>Nr1h3</i> knockout inhibited AAA formation in 2 mouse models. Loss of LXRα function prevented extracellular matrix degeneration, inflammation, and vascular smooth muscle cell phenotypic switching. <i>Uhrf1</i>, an epigenetic master regulator, was identified as a direct target gene of LXRα by integrated analysis of transcriptome sequencing and chromatin immunoprecipitation sequencing. Susceptibility to AAA development was consistently enhanced by UHRF1 (ubiquitin-like containing PHD and RING finger domains 1) in both angiotensin II- and CaCl<sub>2</sub>-induced mouse models. We then determined the CpG methylation status and promoter accessibility of UHRF1-mediated genes using CUT&amp;Tag (cleavage under targets and tagmentation), RRBS (reduced representation bisulfite sequencing), and ATAC-seq (assay for transposase-accessible chromatin with sequencing) in vascular smooth muscle cells, which revealed that the recruitment of UHRF1 to the promoter of miR-26b led to DNA hypermethylation accompanied by relatively closed chromatin states, and caused downregulation of miR-26b expression in AAA. Regarding clinical significance, we found that underexpression of miR-26b-3p correlated with high risk in patients with AAA. Maintaining miR-26b-3p expression prevented AAA progression and alleviated the overall pathological process.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our study reveals a pivotal role of the LXRα/UHRF1/miR-26b-3p axis in AAA and provides potential biomarkers and therapeutic targets for AAA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557060/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557060</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065202>10.1161/CIRCULATIONAHA.123.065202</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557060</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Xiao Guo</dc:creator>
<dc:creator>Jianmei Zhong</dc:creator>
<dc:creator>Yichao Zhao</dc:creator>
<dc:creator>Yanan Fu</dc:creator>
<dc:creator>Ling-Yue Sun</dc:creator>
<dc:creator>Ancai Yuan</dc:creator>
<dc:creator>Junling Liu</dc:creator>
<dc:creator>Alex F Chen</dc:creator>
<dc:creator>Jun Pu</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>LXRα Promotes Abdominal Aortic Aneurysm Formation Through UHRF1 Epigenetic Modification of miR-26b-3p</dc:title>
<dc:identifier>pmid:38557060</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065202</dc:identifier>
</item>
<item>
<title>BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38557054/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: These results suggest a pivotal role of BRCC3 in sustaining pulmonary vascular homeostasis by maintaining the integrity of the BMP signaling (ie, the ALK2-Smad1/5-PPARγ axis) while suppressing TGF-β signaling in PASMCs. Such rebalance of BMP/TGF-β pathways is translationally important for PAH alleviation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: An imbalance of antiproliferative BMP (bone morphogenetic protein) signaling and proliferative TGF-β (transforming growth factor-β) signaling is implicated in the development of pulmonary arterial hypertension (PAH). The posttranslational modification (eg, phosphorylation and ubiquitination) of TGF-β family receptors, including BMPR2 (bone morphogenetic protein type 2 receptor)/ALK2 (activin receptor-like kinase-2) and TGF-βR2/R1, and receptor-regulated (R) Smads significantly affects their activity and thus regulates the target cell fate. BRCC3 modifies the activity and stability of its substrate proteins through K63-dependent deubiquitination. By modulating the posttranslational modifications of the BMP/TGF-β-PPARγ pathway, BRCC3 may play a role in pulmonary vascular remodeling, hence the pathogenesis of PAH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Bioinformatic analyses were used to explore the mechanism of BRCC3 deubiquitinates ALK2. Cultured pulmonary artery smooth muscle cells (PASMCs), mouse models, and specimens from patients with idiopathic PAH were used to investigate the rebalance between BMP and TGF-β signaling in regulating ALK2 phosphorylation and ubiquitination in the context of pulmonary hypertension.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: BRCC3 was significantly downregulated in PASMCs from patients with PAH and animals with experimental pulmonary hypertension. BRCC3, by de-ubiquitinating ALK2 at Lys-472 and Lys-475, activated receptor-regulated Smad1/5/9 (Smad1/5/9), which resulted in transcriptional activation of BMP-regulated PPARγ, p53, and Id1. Overexpression of BRCC3 also attenuated TGF-β signaling by downregulating TGF-β expression and inhibiting phosphorylation of Smad3. Experiments in vitro indicated that overexpression of BRCC3 or the de-ubiquitin-mimetic ALK2-K472/475R attenuated PASMC proliferation and migration and enhanced PASMC apoptosis. In SM22α-BRCC3-Tg mice, pulmonary hypertension was ameliorated because of activation of the ALK2-Smad1/5-PPARγ axis in PASMCs. In contrast, <i>Brcc3</i><sup>-/-</sup> mice showed increased susceptibility of experimental pulmonary hypertension because of inhibition of the ALK2-Smad1/5 signaling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: These results suggest a pivotal role of BRCC3 in sustaining pulmonary vascular homeostasis by maintaining the integrity of the BMP signaling (ie, the ALK2-Smad1/5-PPARγ axis) while suppressing TGF-β signaling in PASMCs. Such rebalance of BMP/TGF-β pathways is translationally important for PAH alleviation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38557054/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38557054</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066430>10.1161/CIRCULATIONAHA.123.066430</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38557054</guid>
<pubDate>Mon, 01 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Hui Shen</dc:creator>
<dc:creator>Ya Gao</dc:creator>
<dc:creator>Dedong Ge</dc:creator>
<dc:creator>Meng Tan</dc:creator>
<dc:creator>Qing Yin</dc:creator>
<dc:creator>Tong-You Wade Wei</dc:creator>
<dc:creator>Fangzhou He</dc:creator>
<dc:creator>Tzong-Yi Lee</dc:creator>
<dc:creator>Zhongyan Li</dc:creator>
<dc:creator>Yuqin Chen</dc:creator>
<dc:creator>Qifeng Yang</dc:creator>
<dc:creator>Zhangyu Liu</dc:creator>
<dc:creator>Xinxin Li</dc:creator>
<dc:creator>Zixuan Chen</dc:creator>
<dc:creator>Yi Yang</dc:creator>
<dc:creator>Zhengang Zhang</dc:creator>
<dc:creator>Patricia A Thistlethwaite</dc:creator>
<dc:creator>Jian Wang</dc:creator>
<dc:creator>Atul Malhotra</dc:creator>
<dc:creator>Jason X-J Yuan</dc:creator>
<dc:creator>John Y-J Shyy</dc:creator>
<dc:creator>Kaizheng Gong</dc:creator>
<dc:date>2024-04-01</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:38557054</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066430</dc:identifier>
</item>
<item>
<title>Barcoding of episodic memories in the hippocampus of a food-caching bird</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38554707/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>The hippocampus is critical for episodic memory. Although hippocampal activity represents place and other behaviorally relevant variables, it is unclear how it encodes numerous memories of specific events in life. To study episodic coding, we leveraged the specialized behavior of chickadees-food-caching birds that form memories at well-defined moments in time whenever they cache food for subsequent retrieval. Our recordings during caching revealed very sparse, transient barcode-like patterns of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 22:S0092-8674(24)00235-6. doi: 10.1016/j.cell.2024.02.032. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The hippocampus is critical for episodic memory. Although hippocampal activity represents place and other behaviorally relevant variables, it is unclear how it encodes numerous memories of specific events in life. To study episodic coding, we leveraged the specialized behavior of chickadees-food-caching birds that form memories at well-defined moments in time whenever they cache food for subsequent retrieval. Our recordings during caching revealed very sparse, transient barcode-like patterns of firing across hippocampal neurons. Each "barcode" uniquely represented a caching event and transiently reactivated during the retrieval of that specific cache. Barcodes co-occurred with the conventional activity of place cells but were uncorrelated even for nearby cache locations that had similar place codes. We propose that animals recall episodic memories by reactivating hippocampal barcodes. Similarly to computer hash codes, these patterns assign unique identifiers to different events and could be a mechanism for rapid formation and storage of many non-interfering memories.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38554707/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38554707</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.032>10.1016/j.cell.2024.02.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38554707</guid>
<pubDate>Sat, 30 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Selmaan N Chettih</dc:creator>
<dc:creator>Emily L Mackevicius</dc:creator>
<dc:creator>Stephanie Hale</dc:creator>
<dc:creator>Dmitriy Aronov</dc:creator>
<dc:date>2024-03-30</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Barcoding of episodic memories in the hippocampus of a food-caching bird</dc:title>
<dc:identifier>pmid:38554707</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.032</dc:identifier>
</item>
<item>
<title>The SPATA5-SPATA5L1 ATPase complex directs replisome proteostasis to ensure genome integrity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38554706/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>Ubiquitin-dependent unfolding of the CMG helicase by VCP/p97 is required to terminate DNA replication. Other replisome components are not processed in the same fashion, suggesting that additional mechanisms underlie replication protein turnover. Here, we identify replisome factor interactions with a protein complex composed of AAA+ ATPases SPATA5-SPATA5L1 together with heterodimeric partners C1orf109-CINP (55LCC). An integrative structural biology approach revealed a molecular architecture of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 22:S0092-8674(24)00250-2. doi: 10.1016/j.cell.2024.03.002. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Ubiquitin-dependent unfolding of the CMG helicase by VCP/p97 is required to terminate DNA replication. Other replisome components are not processed in the same fashion, suggesting that additional mechanisms underlie replication protein turnover. Here, we identify replisome factor interactions with a protein complex composed of AAA+ ATPases SPATA5-SPATA5L1 together with heterodimeric partners C1orf109-CINP (55LCC). An integrative structural biology approach revealed a molecular architecture of SPATA5-SPATA5L1 N-terminal domains interacting with C1orf109-CINP to form a funnel-like structure above a cylindrically shaped ATPase motor. Deficiency in the 55LCC complex elicited ubiquitin-independent proteotoxicity, replication stress, and severe chromosome instability. 55LCC showed ATPase activity that was specifically enhanced by replication fork DNA and was coupled to cysteine protease-dependent cleavage of replisome substrates in response to replication fork damage. These findings define 55LCC-mediated proteostasis as critical for replication fork progression and genome stability and provide a rationale for pathogenic variants seen in associated human neurodevelopmental disorders.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38554706/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38554706</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.002>10.1016/j.cell.2024.03.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38554706</guid>
<pubDate>Sat, 30 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Vidhya Krishnamoorthy</dc:creator>
<dc:creator>Martina Foglizzo</dc:creator>
<dc:creator>Robert L Dilley</dc:creator>
<dc:creator>Angela Wu</dc:creator>
<dc:creator>Arindam Datta</dc:creator>
<dc:creator>Parul Dutta</dc:creator>
<dc:creator>Lisa J Campbell</dc:creator>
<dc:creator>Oksana Degtjarik</dc:creator>
<dc:creator>Laura J Musgrove</dc:creator>
<dc:creator>Antonio N Calabrese</dc:creator>
<dc:creator>Elton Zeqiraj</dc:creator>
<dc:creator>Roger A Greenberg</dc:creator>
<dc:date>2024-03-30</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The SPATA5-SPATA5L1 ATPase complex directs replisome proteostasis to ensure genome integrity</dc:title>
<dc:identifier>pmid:38554706</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.002</dc:identifier>
</item>
<item>
<title>A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38554125/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093/eurheartj/ehae147. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P &lt; .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P &lt; .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P &lt; .001) and decreased procedure (median 47 vs. 60 min; P &lt; .001) and intervention times (85 vs. 95 min; P &lt; .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38554125/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38554125</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae147>10.1093/eurheartj/ehae147</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38554125</guid>
<pubDate>Sat, 30 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Derk Frank</dc:creator>
<dc:creator>Eric Durand</dc:creator>
<dc:creator>Sandra Lauck</dc:creator>
<dc:creator>Douglas F Muir</dc:creator>
<dc:creator>Mark Spence</dc:creator>
<dc:creator>Mariuca Vasa-Nicotera</dc:creator>
<dc:creator>David Wood</dc:creator>
<dc:creator>Francesco Saia</dc:creator>
<dc:creator>Cristóbal A Urbano-Carrillo</dc:creator>
<dc:creator>Damien Bouchayer</dc:creator>
<dc:creator>Vlad Anton Iliescu</dc:creator>
<dc:creator>Christophe Saint Etienne</dc:creator>
<dc:creator>Florence Leclercq</dc:creator>
<dc:creator>Vincent Auffret</dc:creator>
<dc:creator>Lluis Asmarats</dc:creator>
<dc:creator>Carlo Di Mario</dc:creator>
<dc:creator>Aurelie Veugeois</dc:creator>
<dc:creator>Jiri Maly</dc:creator>
<dc:creator>Andreas Schober</dc:creator>
<dc:creator>Luis Nombela-Franco</dc:creator>
<dc:creator>Nikos Werner</dc:creator>
<dc:creator>Joan Antoni Gómez-Hospital</dc:creator>
<dc:creator>Julia Mascherbauer</dc:creator>
<dc:creator>Giuseppe Musumeci</dc:creator>
<dc:creator>Nicolas Meneveau</dc:creator>
<dc:creator>Thibaud Meurice</dc:creator>
<dc:creator>Felix Mahfoud</dc:creator>
<dc:creator>Federico De Marco</dc:creator>
<dc:creator>Tim Seidler</dc:creator>
<dc:creator>Florian Leuschner</dc:creator>
<dc:creator>Patrick Joly</dc:creator>
<dc:creator>Jean-Philippe Collet</dc:creator>
<dc:creator>Ferdinand Vogt</dc:creator>
<dc:creator>Emilio Di Lorenzo</dc:creator>
<dc:creator>Elmar Kuhn</dc:creator>
<dc:creator>Vicente Peral Disdier</dc:creator>
<dc:creator>Violetta Hachaturyan</dc:creator>
<dc:creator>Claudia M Lüske</dc:creator>
<dc:creator>Radka Rakova</dc:creator>
<dc:creator>Wilbert Wesselink</dc:creator>
<dc:creator>Jana Kurucova</dc:creator>
<dc:creator>Peter Bramlage</dc:creator>
<dc:creator>Gemma McCalmont</dc:creator>
<dc:creator>BENCHMARK Investigator Group</dc:creator>
<dc:date>2024-03-30</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study</dc:title>
<dc:identifier>pmid:38554125</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae147</dc:identifier>
</item>
<item>
<title>Flexible scaffold-based cheminformatics approach for polypharmacological drug design</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38552625/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>Effective treatments for complex central nervous system (CNS) disorders require drugs with polypharmacology and multifunctionality, yet designing such drugs remains a challenge. Here, we present a flexible scaffold-based cheminformatics approach (FSCA) for the rational design of polypharmacological drugs. FSCA involves fitting a flexible scaffold to different receptors using different binding poses, as exemplified by IHCH-7179, which adopted a "bending-down" binding pose at 5-HT(2A)R to act as...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 21:S0092-8674(24)00237-X. doi: 10.1016/j.cell.2024.02.034. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Effective treatments for complex central nervous system (CNS) disorders require drugs with polypharmacology and multifunctionality, yet designing such drugs remains a challenge. Here, we present a flexible scaffold-based cheminformatics approach (FSCA) for the rational design of polypharmacological drugs. FSCA involves fitting a flexible scaffold to different receptors using different binding poses, as exemplified by IHCH-7179, which adopted a "bending-down" binding pose at 5-HT<sub>2A</sub>R to act as an antagonist and a "stretching-up" binding pose at 5-HT<sub>1A</sub>R to function as an agonist. IHCH-7179 demonstrated promising results in alleviating cognitive deficits and psychoactive symptoms in mice by blocking 5-HT<sub>2A</sub>R for psychoactive symptoms and activating 5-HT<sub>1A</sub>R to alleviate cognitive deficits. By analyzing aminergic receptor structures, we identified two featured motifs, the "agonist filter" and "conformation shaper," which determine ligand binding pose and predict activity at aminergic receptors. With these motifs, FSCA can be applied to the design of polypharmacological ligands at other receptors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38552625/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38552625</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.034>10.1016/j.cell.2024.02.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38552625</guid>
<pubDate>Fri, 29 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Zhangcheng Chen</dc:creator>
<dc:creator>Jing Yu</dc:creator>
<dc:creator>Huan Wang</dc:creator>
<dc:creator>Peiyu Xu</dc:creator>
<dc:creator>Luyu Fan</dc:creator>
<dc:creator>Fengxiu Sun</dc:creator>
<dc:creator>Sijie Huang</dc:creator>
<dc:creator>Pei Zhang</dc:creator>
<dc:creator>He Huang</dc:creator>
<dc:creator>Shuo Gu</dc:creator>
<dc:creator>Bowen Zhang</dc:creator>
<dc:creator>Yue Zhou</dc:creator>
<dc:creator>Xiaobo Wan</dc:creator>
<dc:creator>Gang Pei</dc:creator>
<dc:creator>H Eric Xu</dc:creator>
<dc:creator>Jianjun Cheng</dc:creator>
<dc:creator>Sheng Wang</dc:creator>
<dc:date>2024-03-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Flexible scaffold-based cheminformatics approach for polypharmacological drug design</dc:title>
<dc:identifier>pmid:38552625</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.034</dc:identifier>
</item>
<item>
<title>Mastigoneme structure reveals insights into the O-linked glycosylation code of native hydroxyproline-rich helices</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38552624/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>Hydroxyproline-rich glycoproteins (HRGPs) are a ubiquitous class of protein in the extracellular matrices and cell walls of plants and algae, yet little is known of their native structures or interactions. Here, we used electron cryomicroscopy (cryo-EM) to determine the structure of the hydroxyproline-rich mastigoneme, an extracellular filament isolated from the cilia of the alga Chlamydomonas reinhardtii. The structure demonstrates that mastigonemes are formed from two HRGPs (a filament of MST1...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 22:S0092-8674(24)00253-8. doi: 10.1016/j.cell.2024.03.005. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Hydroxyproline-rich glycoproteins (HRGPs) are a ubiquitous class of protein in the extracellular matrices and cell walls of plants and algae, yet little is known of their native structures or interactions. Here, we used electron cryomicroscopy (cryo-EM) to determine the structure of the hydroxyproline-rich mastigoneme, an extracellular filament isolated from the cilia of the alga Chlamydomonas reinhardtii. The structure demonstrates that mastigonemes are formed from two HRGPs (a filament of MST1 wrapped around a single copy of MST3) that both have hyperglycosylated poly(hydroxyproline) helices. Within the helices, O-linked glycosylation of the hydroxyproline residues and O-galactosylation of interspersed serine residues create a carbohydrate casing. Analysis of the associated glycans reveals how the pattern of hydroxyproline repetition determines the type and extent of glycosylation. MST3 possesses a PKD2-like transmembrane domain that forms a heteromeric polycystin-like cation channel with PKD2 and SIP, explaining how mastigonemes are tethered to ciliary membranes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38552624/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38552624</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.005>10.1016/j.cell.2024.03.005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38552624</guid>
<pubDate>Fri, 29 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Jin Dai</dc:creator>
<dc:creator>Meisheng Ma</dc:creator>
<dc:creator>Qingwei Niu</dc:creator>
<dc:creator>Robyn J Eisert</dc:creator>
<dc:creator>Xiangli Wang</dc:creator>
<dc:creator>Poulomi Das</dc:creator>
<dc:creator>Karl F Lechtreck</dc:creator>
<dc:creator>Susan K Dutcher</dc:creator>
<dc:creator>Rui Zhang</dc:creator>
<dc:creator>Alan Brown</dc:creator>
<dc:date>2024-03-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Mastigoneme structure reveals insights into the O-linked glycosylation code of native hydroxyproline-rich helices</dc:title>
<dc:identifier>pmid:38552624</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.005</dc:identifier>
</item>
<item>
<title>Short-distance vesicle transport via phase separation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38552623/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>In addition to long-distance molecular motor-mediated transport, cellular vesicles also need to be moved at short distances with defined directions to meet functional needs in subcellular compartments but with unknown mechanisms. Such short-distance vesicle transport does not involve molecular motors. Here, we demonstrate, using synaptic vesicle (SV) transport as a paradigm, that phase separation of synaptic proteins with vesicles can facilitate regulated, directional vesicle transport between...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 21:S0092-8674(24)00251-4. doi: 10.1016/j.cell.2024.03.003. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In addition to long-distance molecular motor-mediated transport, cellular vesicles also need to be moved at short distances with defined directions to meet functional needs in subcellular compartments but with unknown mechanisms. Such short-distance vesicle transport does not involve molecular motors. Here, we demonstrate, using synaptic vesicle (SV) transport as a paradigm, that phase separation of synaptic proteins with vesicles can facilitate regulated, directional vesicle transport between different presynaptic bouton sub-compartments. Specifically, a large coiled-coil scaffold protein Piccolo, in response to Ca<sup>2+</sup> and via its C2A domain-mediated Ca<sup>2+</sup> sensing, can extract SVs from the synapsin-clustered reserve pool condensate and deposit the extracted SVs onto the surface of the active zone protein condensate. We further show that the Trk-fused gene, TFG, also participates in COPII vesicle trafficking from ER to the ER-Golgi intermediate compartment via phase separation. Thus, phase separation may play a general role in short-distance, directional vesicle transport in cells.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38552623/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38552623</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.003>10.1016/j.cell.2024.03.003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38552623</guid>
<pubDate>Fri, 29 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Hua Qiu</dc:creator>
<dc:creator>Xiandeng Wu</dc:creator>
<dc:creator>Xiaoli Ma</dc:creator>
<dc:creator>Shulin Li</dc:creator>
<dc:creator>Qixu Cai</dc:creator>
<dc:creator>Marcelo Ganzella</dc:creator>
<dc:creator>Liang Ge</dc:creator>
<dc:creator>Hong Zhang</dc:creator>
<dc:creator>Mingjie Zhang</dc:creator>
<dc:date>2024-03-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Short-distance vesicle transport via phase separation</dc:title>
<dc:identifier>pmid:38552623</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.003</dc:identifier>
</item>
<item>
<title>Spatial proteomics in neurons at single-protein resolution</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38552614/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240402041101&amp;v=2.18.0.post9+e462414
      <description>To understand biological processes, it is necessary to reveal the molecular heterogeneity of cells by gaining access to the location and interaction of all biomolecules. Significant advances were achieved by super-resolution microscopy, but such methods are still far from reaching the multiplexing capacity of proteomics. Here, we introduce secondary label-based unlimited multiplexed DNA-PAINT (SUM-PAINT), a high-throughput imaging method that is capable of achieving virtually unlimited...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 28;187(7):1785-1800.e16. doi: 10.1016/j.cell.2024.02.045.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">To understand biological processes, it is necessary to reveal the molecular heterogeneity of cells by gaining access to the location and interaction of all biomolecules. Significant advances were achieved by super-resolution microscopy, but such methods are still far from reaching the multiplexing capacity of proteomics. Here, we introduce secondary label-based unlimited multiplexed DNA-PAINT (SUM-PAINT), a high-throughput imaging method that is capable of achieving virtually unlimited multiplexing at better than 15 nm resolution. Using SUM-PAINT, we generated 30-plex single-molecule resolved datasets in neurons and adapted omics-inspired analysis for data exploration. This allowed us to reveal the complexity of synaptic heterogeneity, leading to the discovery of a distinct synapse type. We not only provide a resource for researchers, but also an integrated acquisition and analysis workflow for comprehensive spatial proteomics at single-protein resolution.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38552614/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240402041101&v=2.18.0.post9+e462414">38552614</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.045>10.1016/j.cell.2024.02.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38552614</guid>
<pubDate>Fri, 29 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Eduard M Unterauer</dc:creator>
<dc:creator>Sayedali Shetab Boushehri</dc:creator>
<dc:creator>Kristina Jevdokimenko</dc:creator>
<dc:creator>Luciano A Masullo</dc:creator>
<dc:creator>Mahipal Ganji</dc:creator>
<dc:creator>Shama Sograte-Idrissi</dc:creator>
<dc:creator>Rafal Kowalewski</dc:creator>
<dc:creator>Sebastian Strauss</dc:creator>
<dc:creator>Susanne C M Reinhardt</dc:creator>
<dc:creator>Ana Perovic</dc:creator>
<dc:creator>Carsten Marr</dc:creator>
<dc:creator>Felipe Opazo</dc:creator>
<dc:creator>Eugenio F Fornasiero</dc:creator>
<dc:creator>Ralf Jungmann</dc:creator>
<dc:date>2024-03-29</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Spatial proteomics in neurons at single-protein resolution</dc:title>
<dc:identifier>pmid:38552614</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.045</dc:identifier>
</item>





























</channel>
</rss>